about
In vivo experience with natural scaffolds for myocardial infarction: the times they are a-changin'Impact of umbilical cord blood-derived mesenchymal stem cells on cardiovascular researchHuman umbilical cord blood-derived mesenchymal stem cells promote vascular growth in vivoDiffering prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysisNew approaches to the pharmacological treatment of anginaSoluble ST2 monitoring provides additional risk stratification for outpatients with decompensated heart failurePrognostic value of QT/RR slope in predicting mortality in patients with congestive heart failure.ST2 and patient prognosis in chronic heart failure.The MUSIC Risk score: a simple method for predicting mortality in ambulatory patients with chronic heart failure.Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction.Obesity paradox and risk of sudden death in heart failure results from the MUerte Subita en Insuficiencia cardiaca (MUSIC) study.Left atrial enlargement and NT-proBNP as predictors of sudden cardiac death in patients with heart failure.Association of blood pressure and its evolving changes with the survival of patients with heart failure.Risk stratification of mortality in patients with heart failure and left ventricular ejection fraction >35%.Low atrial fibrillatory rate is associated with poor outcome in patients with mild to moderate heart failure.Reduced Irregularity of Ventricular Response During Atrial Fibrillation and Long-term Outcome in Patients With Heart Failure.The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data.Practical data handling pipeline improves performance of qPCR-based circulating miRNA measurements.Differential diagnosis of rSr' pattern in leads V1 -V2. Comprehensive review and proposed algorithm.Comparison of two preclinical myocardial infarct models: coronary coil deployment versus surgical ligationElectromechanical Conditioning of Adult Progenitor Cells Improves Recovery of Cardiac Function After Myocardial Infarction.Engineered 3D bioimplants using elastomeric scaffold, self-assembling peptide hydrogel, and adipose tissue-derived progenitor cells for cardiac regeneration.Annual summary 2010: bibliometric data, activities, and new production of the journal.The role and potential of umbilical cord blood in an era of new therapies: a reviewLimited value of cystatin-C over estimated glomerular filtration rate for heart failure risk stratification.Identification of temporal and region-specific myocardial gene expression patterns in response to infarction in swine.New insights into elastin and vascular disease.Structural heart disease and ST2: cross-sectional and longitudinal associations with echocardiography.Ventricular non-compaction cardiomyopathy: CMR and pathology findingsPostinfarction Functional Recovery Driven by a Three-Dimensional Engineered Fibrin Patch Composed of Human Umbilical Cord Blood-Derived Mesenchymal Stem CellsNeoinnervation and neovascularization of acellular pericardial-derived scaffolds in myocardial infarcts.B-type natriuretic peptide release in the coronary effluent after acute transient ischaemia in humansFetal-maternal interface: a chronicle of allogeneic coexistence.Pretreatment with corticosteroids attenuates the efficacy of colchicine in preventing recurrent pericarditis: a multi-centre all-case analysis.Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis.Predictive value of beat-to-beat QT variability index across the continuum of left ventricular dysfunction: competing risks of noncardiac or cardiovascular death and sudden or nonsudden cardiac deathTransient biventricular dysfunction following pericardiocentesis.Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure.Statins in heart failure: the paradox between large randomized clinical trials and real life.First-in-man Safety and Efficacy of the Adipose Graft Transposition Procedure (AGTP) in Patients With a Myocardial Scar.
P50
Q26775715-8656ECDC-045A-40E4-81E8-B1F0920F3374Q26864630-A75012C6-0AAB-4514-8DD7-0E01D0AB1F02Q27336125-ED9C46A4-1EFB-491A-8777-8CDEF0E4E659Q28085643-FA6A0FB0-C870-4DBA-8400-62024EE9101DQ28191679-499197FC-60EE-4A09-B845-08BD4F1994A4Q28294246-5B0D2E30-EF13-4FB0-AD91-63EA9180A206Q30369972-35E3056E-8DA3-4B99-A14F-30F703620267Q30371593-430E5B65-CB76-476E-8BC9-43D05B9A4D2AQ30375145-253F3A5E-C9BF-4B28-885A-F90168AB0467Q30382926-2A8DAE5C-7026-438D-A003-721AB6772D6FQ30397600-5D13BB43-5C1F-4F8A-9B5C-4FDFF3D855D6Q30542622-FBA4A863-530B-4288-9271-2DEA1A53DE20Q30544010-8093F0CE-8B5A-487D-81A7-CF143FD77E8BQ30544638-B534381A-5F52-4E77-AE4A-466F3DC08098Q30557370-32024C92-9E60-49BB-A58F-6CEC687D9A39Q30569240-FA966B3E-6BDA-4E3B-BAB8-8EA348BB6134Q30686199-F6E27D91-8BC5-4862-95AF-5D2C1C6C535EQ31162287-D254177B-8DB7-46AE-87CB-2746474E182AQ33165126-3CB52DE2-5690-4425-98DF-88173609EA02Q33718007-CBDDE1F1-8009-411E-8E1D-9D308FCADC76Q33722403-0B48674E-5E5D-43C1-B351-BBD37809FADBQ33758005-03B0A9CE-6C46-4ABF-A678-47400F81BD6DQ33767192-1BEA9635-C84B-46F9-BA8A-016984D94A27Q34483172-C8B96C72-DA45-4769-A099-7BAD12FC696BQ34512274-FE346E38-FBB5-4420-9744-F570CC0292CBQ34571329-E2DC804B-0D10-4F47-80EF-EE54AC202187Q35167493-3618799F-FB15-433B-9CDC-C4C66A21CF49Q35564976-8575C5E1-0E64-4C1C-8057-21448769D4C8Q35584183-E9A00651-7A73-4E34-90D6-C61F4CC3F36EQ35878873-529D3BA6-AF36-44A9-983D-346B8D1DFF37Q35930186-479B3E53-5F65-4F8A-AEE9-F13B60C7EAF7Q35954229-36AFE5BD-62BB-4F6E-86EE-37FF972B8D5AQ36019271-7F186A44-C238-4CBB-96AE-22B0286CF80DQ36065406-F1206B02-1552-42C6-B9D8-3A29DBEE89EAQ36183563-D653C8DD-F362-4B20-92F6-67ACD0FCDEA3Q36203696-351A1C07-2B17-4640-8F84-2303317D2F22Q36235854-FA4C9957-A2C1-4D57-BF60-189F736D0C85Q36277842-9A23017D-6076-43C5-BF7A-D61B023D1171Q36522875-3DADEE24-39EF-476B-A1AE-EA71530F12ACQ37008464-56D8117A-DEF0-430A-822C-2BD569E4026A
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Antoni Bayes-Genis
@ast
Antoni Bayes-Genis
@en
Antoni Bayes-Genis
@es
Antoni Bayes-Genis
@nl
type
label
Antoni Bayes-Genis
@ast
Antoni Bayes-Genis
@en
Antoni Bayes-Genis
@es
Antoni Bayes-Genis
@nl
prefLabel
Antoni Bayes-Genis
@ast
Antoni Bayes-Genis
@en
Antoni Bayes-Genis
@es
Antoni Bayes-Genis
@nl
P1053
C-4002-2015
P106
P21
P31
P3829
P496
0000-0002-3044-197X